Therefore, the roles of aromatase and seladin-1 and their interactions in neurodegenerative events such as Alzheimer’s disease (AD), ischemia/reperfusion injury (stroke), and epilepsy are also discussed in this review. This evidence concerns the gene CYP19A1 and early-onset autosomal dominant Alzheimer disease.